WeightWatchers CEO Sima Sistani Steps Down Amid Struggles with Weight-Loss Drugs

Sistani's departure follows a major pivot to weight-loss medications and a sharp decline in company stock.

Sima Sistani, CEO of WeightWatchers for two years, has stepped down effective immediately.
Board member Tara Comonte, former CEO of Shake Shack, has been appointed as interim CEO.
Under Sistani's leadership, WeightWatchers acquired telehealth platform Sequence to prescribe weight-loss drugs like Ozempic and Wegovy.
Despite the strategic shift, WeightWatchers' stock has plunged over 90% year-to-date, reaching record lows.
The company faces significant challenges as GLP-1 weight-loss drugs disrupt the traditional weight management industry.